Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Syntec Optics' Q1 revenue of $6.5M, down 8.5% YoY, and a GAAP loss of $0.02 per share raise cash burn concerns for the micro-cap optics maker. The 10-Q filing will be the next catalyst.
ValueAct's Q1 13F reveals new KKR, Spotify positions alongside exits from Disney and Insight. The rotation signals sector tilts toward asset management and streaming.
Birchcliff Energy shareholders reelected all seven directors, confirming board continuity for the Montney-focused producer. The vote removes a governance distraction, leaving natural gas prices and well productivity as the next catalysts.
Myanmar's military junta introduces draft law enabling life imprisonment and possible death penalty for large-scale crypto fraud linked to Southeast Asian scam compounds.
Revolut secures FCA approval for private wealth and leveraged products, pairing with its crypto licence and UK banking charter. The £500k entry point targets an underserved segment between Coutts and retail.
DBS analysts see Singapore's non-oil domestic exports extending gains on AI demand, supporting the SGD. The next NODX print and MAS October policy statement are key catalysts.
Citius Q2: GAAP EPS of -$0.95, product revenue $1.7M. This first quarter of commercial sales sets up a cash-burn vs revenue trajectory test for CTXR.
RedStone's Settle layer aims to tokenize real-world assets for DeFi collateral. No partnerships or regulatory sign-off yet. The $30B target faces execution risk.
a16z calls the CLARITY Act's May 14 Senate Banking vote a potential 1933 moment, replacing enforcement with statutory rules for digital asset markets.
Dan Loeb's Third Point dumped Microsoft and Nvidia while adding Meta and Alphabet. The 13F reveals a bet on AI monetization over chip supply.
MiNK Therapeutics initiates 90-patient randomized Phase II ARDS trial; initial data in 2H 2026 creates a binary catalyst for INKT stock.
MiNK Therapeutics presented Phase II gastric data at AACR and IPF findings at Keystone. The stock's next move depends on partnership interest and cash runway.
ExxonMobil hit a record high of $176.41 after Q4 earnings beat on 4.7M boe/d production. The $20B buyback plan and 2030 earnings target of $25B set the forward case.
ING analysts flag widening gap between consumer inflation and GDP as energy costs erode real incomes. Yen remains under pressure as BoJ faces stagflationary dilemma.
PMI data from major economies will set the tone for central bank guidance, with EUR/USD and USD/JPY facing key positioning tests after extreme COT bets.
Bitcoin and Ethereum lead $388M derivatives unwind; funding rates reset over 48-72 hours will reveal if this is a healthy flush or the start of deeper drawdown.
Land & Buildings' Q1 13F shows a rotation out of storage and into single-family rental and data centers. The activist fund added INVH, exited NSA, and boosted DLR. AlphaScala scores all three REITs as Mixed, suggesting the trade is not a consensus call.
Expion360 Q1 GAAP EPS -$0.17 on revenue of $1.6M, down 22% Y/Y. Cash at $3.1M. The 22% revenue drop and cash burn create a binary outcome for XPON.
S&P 500 breaches 7,500 then reverses as Kevin Warsh confirmation sparks liquidity fears. Dollar surges; FOMC minutes and global PMIs test the thesis.
Tech stocks sold off Friday as Treasury yields climbed post-U.S.-China summit. The yield move pressures growth stocks via discount rates and term premium repricing.
Tokenized money market funds let treasurers swap cash for digital shares instantly. Here is how the mechanics work and what it means for liquidity management.
Chromebook Q1 shipments fell 11% YoY as education demand stalled. Japan's GIGA School Program 2.0 delay removes the key catalyst. Vendor splits and timeline to watch.
Baker Hughes survey shows fourth consecutive weekly gain. The streak shifts focus from maintenance drilling to potential supply growth, with implications for USO and BKR.
Illicit crypto funds on-chain hit $75-$83B, up 28% YoY. Transparency creates a regulatory ticking clock for exchanges and DeFi protocols.
OCBC analysts see dollar strength capping Asian FX gains despite RMB-led optimism. Yield differentials and positioning contain the rally. Next catalysts: US CPI and PBOC fixing.
PFC and REC boards meet Saturday to discuss merger. A 25,000 crore capital infusion is needed to keep government stake above 51%. Analysts question feasibility amid fiscal squeeze.
Bunq filed for a Mexican banking license to serve global citizens with ties to Mexico. The move tests whether European neobanks can scale beyond Europe.
Vote was 241-200. The bill aligns Poland with EU crypto rules after President Nawrocki blocked earlier versions. Next step: presidential signature or another veto within 21 days.
Avant Genomics raised $3M+ for automated liquid biopsy sample prep. The round signals VC confidence in solving a key bottleneck in precision oncology. Next milestone: manufacturing scale-up and clinical validation.
CFTC data shows yen net short positions jumped 21.7% to ¥-75.1K. The carry trade remains dominant, but extreme positioning raises squeeze risk ahead of BoJ and US data.